LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 89

Search options

  1. Article ; Online: Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiringmechanical ventilation.

    Baker, S. A. / Kowk, S. / Berry, G. J. / Montine, T. J.

    Abstract: Mortality due to Covid-19 is highly associated with advanced age, owing in large part to severe lower respiratory tract infection. SARS-CoV-2 utilizes the host ACE2 receptor for infection. Whether ACE2 abundance in the lung contributes to age-associated ... ...

    Abstract Mortality due to Covid-19 is highly associated with advanced age, owing in large part to severe lower respiratory tract infection. SARS-CoV-2 utilizes the host ACE2 receptor for infection. Whether ACE2 abundance in the lung contributes to age-associated vulnerability is currently unknown. We set out to characterize the RNA and protein expression profiles of ACE2 in aging human lung in the context of phenotypic parameters likely to affect lung physiology. Examining publicly available RNA sequencing data, we discovered that mechanical ventilation is a critical variable affecting lung ACE2 levels. Therefore, we investigated ACE2 protein abundance in patients either requiring mechanical ventilation or spontaneously breathing. ACE2 distribution and expression were determined in archival lung samples by immunohistochemistry (IHC). Tissues were selected from the specimen inventory at a large teaching hospital collected between 2010-2020. Twelve samples were chosen from patients receiving mechanical ventilation for acute hypoxic respiratory failure (AHRF). Twenty samples were selected from patients not requiring ventilation. We compared samples across age, ranging from 40-83 years old in the ventilated cohort and 14-80 years old in the non-ventilated cohort. Within the alveolated parenchyma, ACE2 expression is predominantly observed in type II pneumocytes (or alveolar type II / AT2 cells) and alveolar macrophages. All 12 samples from our ventilated cohort showed histologic features of diffuse alveolar damage including reactive, proliferating AT2 cells. In these cases, ACE2 was strongly upregulated with age when normalized to lung area (p = 0.004) or cellularity (p = 0.003), associated with prominent expression in AT2 cells. In non-ventilated individuals, AT2 cell reactive changes were not observed and ACE2 expression did not change with age when normalized to lung area (p = 0.231) or cellularity (p = 0.349). Additionally, we observed prominent pulmonary endothelial ACE2 expression in 2 patients on either an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB). In summary, ACE2 expression increases with age in the setting of alveolar damage observed in patients on mechanical ventilation, providing a potential mechanism for higher Covid-19 mortality in the elderly.
    Keywords covid19
    Publisher MedRxiv; WHO
    Document type Article ; Online
    DOI 10.1101/2020.07.05.20140467
    Database COVID19

    Kategorien

  2. Article: Behaviour of ?-methylserotonin in rat brain synaptosomes.

    Montine, T J / Sourkes, T L

    Neurochemistry international

    2009  Volume 15, Issue 2, Page(s) 227–231

    Abstract: Twenty-four h after administration of ?-methyl-dl-tryptophan (AMTP) to rats intrasynaptosomal ?-methylserotonin (AM5HT) levels were 5.5-fold greater than those of serotonin (5HT) in control animals, and were accompanied by a 90% reduction in 5HT ... ...

    Abstract Twenty-four h after administration of ?-methyl-dl-tryptophan (AMTP) to rats intrasynaptosomal ?-methylserotonin (AM5HT) levels were 5.5-fold greater than those of serotonin (5HT) in control animals, and were accompanied by a 90% reduction in 5HT concentrations. Behaviour of AM5HT in nerve terminals was examined by use of synaptosomes prepared from brains of rats given AMTP. The relative depletion of intrasynaptosomal AM5HT and 5HT levels induced by K(+) was equivalent over the range of 5-100 mM KCl. The concentration of intrasynaptosomal AM5HT was significantly reduced in rats treated with reserpine following AMTP injection. Similarly, rats treated with a neurotoxic regimen of p-chloroamphetamine prior to AMTP administration also showed marked reduction in synaptosomal AM5HT levels. Synaptosomes prepared from brains of untreated rats accumulated AM5HT in a temperature-dependent fashion that was inhibited by co-incubation with 5HT or fluoxetine. These results support the hypotheses that AM5HT is stored in synaptosomes derived from serotonergic neurons and that AM5HT is accumulated into and released from brain synaptosomes in a manner similar to 5HT.
    Language English
    Publishing date 2009-11-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 283190-9
    ISSN 1872-9754 ; 0197-0186
    ISSN (online) 1872-9754
    ISSN 0197-0186
    DOI 10.1016/0197-0186(89)90105-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Characterization of cognitive impairments and neurotransmitter changes in a novel transgenic mouse lacking Slc10a4.

    Melief, E J / Gibbs, J T / Li, X / Morgan, R G / Keene, C D / Montine, T J / Palmiter, R D / Darvas, M

    Neuroscience

    2016  Volume 324, Page(s) 399–406

    Abstract: An orphan member of the solute carrier (SLC) family SLC10, SLC10A4 has been found to be enriched in midbrain and brainstem neurons and has been found to co-localize with and to affect dopamine (DA) homeostasis. We generated an SLC10A4 knockout mouse ( ... ...

    Abstract An orphan member of the solute carrier (SLC) family SLC10, SLC10A4 has been found to be enriched in midbrain and brainstem neurons and has been found to co-localize with and to affect dopamine (DA) homeostasis. We generated an SLC10A4 knockout mouse (Slc10a4(Δ/Δ)) using Cre-targeted recombination, and characterized behavioral measures of motor and cognitive function as well as DA and acetylcholine (ACh) levels in midbrain and brainstem. In agreement with previous studies, Slc10a4 mRNA was preferentially expressed in neurons in the brains of wild-type (Slc10a4(+/+)) mice and was enriched in dopaminergic and cholinergic regions. Slc10a4(Δ/Δ) mice had no impairment in motor function or novelty-induced exploratory behaviors but performed significantly worse in measures of spatial memory and cognitive flexibility. Slc10a4(Δ/Δ) mice also did not differ from Slc10a4(+/+) in measures of anxiety. High-performance liquid chromatography (HPLC) measures on tissue punches taken from the dorsal and ventral striatum reveal a decrease in DA content and a corresponding increase in the metabolite 3,4-dihydroxyphenylacetic acid (DOPAC), indicating an increase in DA turnover. Punches taken from the brainstem revealed a decrease in ACh as compared with Slc10a4(+/+) littermates. Together, these data indicate that loss of SLC10A4 protein results in neurotransmitter imbalance and cognitive impairment.
    MeSH term(s) 3,4-Dihydroxyphenylacetic Acid/metabolism ; Acetylcholine/metabolism ; Animals ; Brain/metabolism ; Chromatography, High Pressure Liquid ; Cognition/physiology ; Cognitive Dysfunction/metabolism ; Disease Models, Animal ; Dopamine/metabolism ; Exploratory Behavior/physiology ; Female ; Learning Disorders/metabolism ; Male ; Mice, Inbred C57BL ; Mice, Knockout ; Motor Activity/physiology ; Nerve Tissue Proteins/genetics ; Nerve Tissue Proteins/metabolism ; RNA, Messenger/metabolism ; Spatial Learning/physiology ; Vesicular Transport Proteins/genetics ; Vesicular Transport Proteins/metabolism
    Chemical Substances Nerve Tissue Proteins ; RNA, Messenger ; SLC10A4 protein, mouse ; Vesicular Transport Proteins ; 3,4-Dihydroxyphenylacetic Acid (102-32-9) ; Acetylcholine (N9YNS0M02X) ; Dopamine (VTD58H1Z2X)
    Language English
    Publishing date 2016-06-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 196739-3
    ISSN 1873-7544 ; 0306-4522
    ISSN (online) 1873-7544
    ISSN 0306-4522
    DOI 10.1016/j.neuroscience.2016.03.037
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Lipoproteins and lipid peroxidation in Alzheimer's disease.

    Bassett, C N / Montine, T J

    The journal of nutrition, health & aging

    2003  Volume 7, Issue 1, Page(s) 24–29

    Abstract: Alzheimer's Disease (AD) is a clinical-pathological entity that probably derives from different causes. Mounting evidence strongly implicates regionally increased oxidative damage to brain beyond what occurs with aging as one of the processes that may ... ...

    Abstract Alzheimer's Disease (AD) is a clinical-pathological entity that probably derives from different causes. Mounting evidence strongly implicates regionally increased oxidative damage to brain beyond what occurs with aging as one of the processes that may contribute to AD progression. While several different classes of molecules may be affected, lipid peroxidation is thought to be a prominent and especially deleterious form of oxidative damage in brain due to this organ's relative enrichment in polyunsaturated fatty acids. Our laboratory recently has demonstrated that lipoproteins in AD brain extracellular fluid are more vulnerable to oxidation than lipoproteins in control brain extracellular fluid. Apolipoprotein E (apoE) is the principal apolipoprotein in the central nervous system (CNS), and it serves as the major apolipoprotein that is capable of lipid transport and regulation of lipid metabolism through known receptor-mediated processes. Moreover, inheritance of the APOE4 allele represents the strongest genetic risk factor for sporadic AD. Evidence suggests that apoE isoforms may specifically influence the cellular distribution of lipid peroxidation products in brain and may therefore contribute to the stratification of risk for AD associated with APOE. Here, we review possible mechanisms whereby lipoprotein trafficking and lipid peroxidation converge to contribute to neurodegeneration in AD brain.
    MeSH term(s) Aged ; Alzheimer Disease/metabolism ; Alzheimer Disease/physiopathology ; Humans ; Lipid Peroxidation/physiology ; Lipoproteins/metabolism
    Chemical Substances Lipoproteins
    Language English
    Publishing date 2003
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 2081921-3
    ISSN 1760-4788 ; 1279-7707
    ISSN (online) 1760-4788
    ISSN 1279-7707
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: CSF lipoproteins and Alzheimer's disease.

    Neely, M D / Montine, T J

    The journal of nutrition, health & aging

    2002  Volume 6, Issue 6, Page(s) 383–391

    Abstract: Alterations in lipid homeostasis have been suggested to play a role in the pathogenesis of Alzheimer's disease (AD). This hypothesis is supported by the observed changes in lipid content and composition of AD brains when compared to age-matched control ... ...

    Abstract Alterations in lipid homeostasis have been suggested to play a role in the pathogenesis of Alzheimer's disease (AD). This hypothesis is supported by the observed changes in lipid content and composition of AD brains when compared to age-matched control brains. The association between the e4 allele of the apolipoprotein E gene and increased risk of AD implicates lipoproteins in the pathogenesis. Lipoproteins are macromolecular particles responsible for lipid trafficking and metabolism. CNS lipoproteins are different from their plasma counter parts. We review the current understanding of the structure and functions of CNS lipoproteins. In addition to mediating lipid trafficking and metabolism, there is increasing evidence that apoE-containing lipoproteins are also involved in dendritic remodeling and synaptogensis and maintenance of the synapto-dendritic complexity during aging. Interestingly, these functions have been shown to be apoE-isoform specific with apoE4 lacking the activities of apoE3 and apoE2. In addition to the association between apoE4 and an increased risk of AD, oxidative stress is believed to play a role in the pathogenesis of this disease. Indeed evidence of lipid peroxidation in cerebral spinal fluid (CSF) lipoproteins from AD patients has been observed. Oxidation of lipoproteins not only eliminates their supportive roles in neurite outgrowth and synaptogenesis, but actually transforms them into neurotoxic agents. The elucidation of the pathways and mechanisms by which apoE-isoform and oxidation affect lipoprotein function in the CNS remains a challenge for scientist in the field of neurodegenerative disease.
    MeSH term(s) Alzheimer Disease/cerebrospinal fluid ; Alzheimer Disease/etiology ; Alzheimer Disease/metabolism ; Apolipoproteins E/cerebrospinal fluid ; Apolipoproteins E/genetics ; Brain/metabolism ; Brain/pathology ; Homeostasis ; Humans ; Lipid Metabolism ; Lipoproteins/cerebrospinal fluid ; Lipoproteins/metabolism ; Neurites/physiology ; Oxidation-Reduction ; Synapses/physiology
    Chemical Substances Apolipoproteins E ; Lipoproteins
    Language English
    Publishing date 2002
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 2081921-3
    ISSN 1760-4788 ; 1279-7707
    ISSN (online) 1760-4788
    ISSN 1279-7707
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Acrolein inhibits respiration in isolated brain mitochondria.

    Picklo, M J / Montine, T J

    Biochimica et biophysica acta

    2001  Volume 1535, Issue 2, Page(s) 145–152

    Abstract: Lipid peroxidation is elevated in diseased regions of brain in several neurodegenerative diseases. Acrolein (2-propenal) is a major cytotoxic product of lipid peroxidation and its adduction to neuronal proteins has been demonstrated in diseased brain ... ...

    Abstract Lipid peroxidation is elevated in diseased regions of brain in several neurodegenerative diseases. Acrolein (2-propenal) is a major cytotoxic product of lipid peroxidation and its adduction to neuronal proteins has been demonstrated in diseased brain regions from patients with Alzheimer's disease. Mitochondrial abnormalities are implicated in several neurodegenerative disorders, and mitochondria are targets of alkenal adduction in vivo. We examined the effects of acrolein upon multiple endpoints associated with the mitochondrial involvement in neurodegenerative disease. Acrolein inhibited state 3 respiration with an IC(50) of approx. 0.4 micromol/mg protein; however, there was no reduction in activity of complexes I-V. This inhibition was prevented by glutathione and N-acetylcysteine. Acrolein did not alter mitochondrial calcium transporter activity or induce cytochrome c release. These studies indicate that acrolein is a potent inhibitor of brain mitochondrial respiration.
    MeSH term(s) Acrolein/pharmacology ; Animals ; Brain/drug effects ; Brain/metabolism ; Calcium/metabolism ; Cytochrome c Group/metabolism ; Lipid Peroxidation ; Male ; Mitochondria/drug effects ; Mitochondria/metabolism ; Neurodegenerative Diseases/metabolism ; Oxygen Consumption/drug effects ; Rats ; Rats, Sprague-Dawley
    Chemical Substances Cytochrome c Group ; Acrolein (7864XYD3JJ) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2001-05-01
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 60-7
    ISSN 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650
    ISSN 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/s0925-4439(00)00093-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies.

    Chibnik, L B / White, C C / Mukherjee, S / Raj, T / Yu, L / Larson, E B / Montine, T J / Keene, C D / Sonnen, J / Schneider, J A / Crane, P K / Shulman, J M / Bennett, D A / De Jager, P L

    Molecular psychiatry

    2017  Volume 23, Issue 6, Page(s) 1521–1529

    Abstract: Tauopathies, including Alzheimer's disease (AD) and other neurodegenerative conditions, are defined by a pathological hallmark: neurofibrillary tangles (NFTs). NFT accumulation is thought to be closely linked to cognitive decline in AD. Here, we perform ... ...

    Abstract Tauopathies, including Alzheimer's disease (AD) and other neurodegenerative conditions, are defined by a pathological hallmark: neurofibrillary tangles (NFTs). NFT accumulation is thought to be closely linked to cognitive decline in AD. Here, we perform a genome-wide association study for NFT pathologic burden and report the association of the PTPRD locus (rs560380, P=3.8 × 10
    MeSH term(s) Aged ; Alzheimer Disease/physiopathology ; Amyloid beta-Peptides/metabolism ; Brain/metabolism ; Cognitive Dysfunction/metabolism ; Female ; Genome-Wide Association Study ; Hippocampus/metabolism ; Humans ; Male ; Middle Aged ; Neurofibrillary Tangles/genetics ; Neurofibrillary Tangles/pathology ; Neurons/metabolism ; Neuropathology/methods ; Plaque, Amyloid/metabolism ; Prospective Studies ; Receptor-Like Protein Tyrosine Phosphatases, Class 2/metabolism ; Receptor-Like Protein Tyrosine Phosphatases, Class 2/physiology ; Tauopathies/metabolism ; tau Proteins/metabolism
    Chemical Substances Amyloid beta-Peptides ; tau Proteins ; PTPRD protein, human (EC 3.1.3.48) ; Receptor-Like Protein Tyrosine Phosphatases, Class 2 (EC 3.1.3.48)
    Language English
    Publishing date 2017-03-21
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1330655-8
    ISSN 1476-5578 ; 1359-4184
    ISSN (online) 1476-5578
    ISSN 1359-4184
    DOI 10.1038/mp.2017.20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Dopamine thioethers in neurodegeneration.

    Sidell, K R / Amamath, V / Montine, T J

    Current topics in medicinal chemistry

    2001  Volume 1, Issue 6, Page(s) 519–527

    Abstract: Dopamine oxidation is proposed to be a significant contributor to mesostriatal dopaminergic neurodegeneration, although the mechanisms are not fully resolved. Recent results from in vitro and in vivo models have suggested that some products from ... ...

    Abstract Dopamine oxidation is proposed to be a significant contributor to mesostriatal dopaminergic neurodegeneration, although the mechanisms are not fully resolved. Recent results from in vitro and in vivo models have suggested that some products from mercapturic acid pathway (MAP) metabolism of oxidized dopamine (DA) may contribute to dopaminergic neurodegeneration, and that at least one product of this pathway, 5-S-cysteinyldopamine (Cys-DA), is elevated in patients with advanced Parkinson's disease (PD). Here we review recent findings on MAP enzymes and their products in rodent brain and in diseased regions of brain from patients with mesostriatal dopaminergic neurodegeneration. We also review the current data and our recent findings on the neurobiological activity of MAP metabolites of oxidized DA. We conclude that human striatum has limited enzymatic capacity for mercapturate formation, that levels of MAP products of oxidized DA are significantly elevated in PD patients with advanced dopaminergic neurodegeneration but not in patients with less severe degeneration, and that Cys-DA interferes with trafficking of DA in vitro and in vivo. These results indicate that Cys-DA may interfere with DAtrafficking in patients with advanced dopaminergic neurodegeneration.
    MeSH term(s) Acetylcysteine/metabolism ; Animals ; Corpus Striatum/metabolism ; Corpus Striatum/pathology ; Dopamine/analogs & derivatives ; Dopamine/metabolism ; Humans ; Nerve Degeneration/etiology ; Nerve Degeneration/metabolism ; Nerve Degeneration/pathology ; Neurodegenerative Diseases/etiology ; Neurodegenerative Diseases/metabolism ; Neurodegenerative Diseases/pathology ; Sulfides/metabolism
    Chemical Substances Sulfides ; 5-S-cysteinyldopamine (99558-89-1) ; Dopamine (VTD58H1Z2X) ; Acetylcysteine (WYQ7N0BPYC)
    Language English
    Publishing date 2001-09-04
    Publishing country United Arab Emirates
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 2064823-6
    ISSN 1873-4294 ; 1568-0266
    ISSN (online) 1873-4294
    ISSN 1568-0266
    DOI 10.2174/1568026013394705
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Wernicke's encephalopathy in a patient with AIDS.

    Montine, T J / Fuller, G N

    AIDS (London, England)

    1993  Volume 7, Issue 5, Page(s) 744–745

    MeSH term(s) Acquired Immunodeficiency Syndrome/complications ; Adult ; Humans ; Male ; Wernicke Encephalopathy/complications ; Wernicke Encephalopathy/diagnosis ; Wernicke Encephalopathy/etiology
    Language English
    Publishing date 1993-05
    Publishing country England
    Document type Case Reports ; Letter
    ZDB-ID 639076-6
    ISSN 1473-5571 ; 0269-9370 ; 1350-2840
    ISSN (online) 1473-5571
    ISSN 0269-9370 ; 1350-2840
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules.

    Neely, M D / Swift, L L / Montine, T J

    Lipids

    2000  Volume 35, Issue 11, Page(s) 1249–1257

    Abstract: Cerebral spinal fluid (CSF) lipoproteins have become a focus of research since the observation that inheritance of particular alleles of the apolipoprotein E gene affects the risk of Alzheimer's disease (AD). There is evidence of increased lipid ... ...

    Abstract Cerebral spinal fluid (CSF) lipoproteins have become a focus of research since the observation that inheritance of particular alleles of the apolipoprotein E gene affects the risk of Alzheimer's disease (AD). There is evidence of increased lipid peroxidation in CSF lipoproteins from patients with AD, but the biological significance of this observation is not known. A characteristic of the AD brain is a disturbance of the neuronal microtubule organization. We have shown previously that 4-hydroxy-2(E)-nonenal, a major product of lipid peroxidation, causes disruption of neuronal microtubules and therefore tested whether oxidized CSF lipoproteins had the same effect. We exposed Neuro 2A cells to human CSF lipoproteins and analyzed the microtubule organization by immunofluorescence. In vitro oxidized human CSF lipoproteins caused disruption of the microtubule network, while their native (nonoxidized) counterparts did not. Microtubule disruption was observed after short exposures (1 h) and lipoprotein concentrations were present in CSF (20 microg/mL), conditions that did not result in loss of cell viability. Importantly, adult bovine CSF lipoproteins, oxidized under identical conditions, had no effect on the microtubule organization of Neuro 2A cells. Comparison of human and bovine CSF lipoproteins revealed similar oxidation-induced modifications of apolipoproteins E and A-I as analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting. Fatty acid analysis revealed substantially lower amounts of unsaturated fatty acids in bovine CSF lipoproteins, when compared to their human counterparts. Our data therefore indicate that oxidized human CSF lipoproteins are detrimental to neuronal microtubules. This effect is species-specific, since equally oxidized bovine CSF lipoproteins left the neuronal microtubule organization unchanged.
    MeSH term(s) Animals ; Apolipoprotein A-I/metabolism ; Apolipoproteins E/metabolism ; Cattle ; Cells, Cultured ; Humans ; Lipoproteins/cerebrospinal fluid ; Lipoproteins/physiology ; Microtubules/metabolism ; Neurons/metabolism ; Neurons/ultrastructure ; Oxidation-Reduction
    Chemical Substances Apolipoprotein A-I ; Apolipoproteins E ; Lipoproteins
    Language English
    Publishing date 2000-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 241539-2
    ISSN 1558-9307 ; 0024-4201
    ISSN (online) 1558-9307
    ISSN 0024-4201
    DOI 10.1007/s11745-000-0641-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top